TRPM2 and breast adenocarcinoma: Increased cell death in MDA-MB-231 breast adenocarcinoma cells due to TRPM2 inhibition is not primarily due to caspase-independent cell death mediated by poly(ADP-ribose) and apoptosis-inducing factor